These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3938854)

  • 41. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
    Saadjian AY; Philip-Jöel FF; Barret A; Levy S; Arnaud AG
    Eur Respir J; 1994 May; 7(5):862-8. PubMed ID: 8050541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of long-term almitrine therapy on sleep hypoxaemia in patients with chronic airways obstruction.
    Racineux JL; Meslier N; Hubert P
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():183s-184s. PubMed ID: 3690029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of almitrine in the treatment of chronic obstructive bronchopneumopathy].
    Bury T; Radermecker M
    Rev Med Liege; 1987 May; 42(9):352-5. PubMed ID: 3299607
    [No Abstract]   [Full Text] [Related]  

  • 44. [Originality of the mode of action of almitrine dimesylate].
    Tellier P
    Presse Med; 1984 Oct; 13(34):2083-9. PubMed ID: 6149536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Almitrine has no effect on gas exchange after bilateral carotid body resection in severe chronic airflow obstruction.
    De Backer W; Vermeire P; Bogaert E; Janssens E; Van Maele R
    Bull Eur Physiopathol Respir; 1985; 21(5):427-32. PubMed ID: 3904873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
    Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
    Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
    Hillebrand M; Siemon G
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():391-3. PubMed ID: 2902610
    [No Abstract]   [Full Text] [Related]  

  • 48. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
    Bury T; Jeannot JP; Ansquer JC; Radermecker M
    Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.
    Bakran I; Vrhovac B; Stangl B; Tabori D; Ivicevic A; Todic V; Kandare F
    Eur J Clin Pharmacol; 1990; 38(3):249-53. PubMed ID: 2187700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
    Daskalopoulou E; Patakas D; Tsara V; Zoglopitis F; Maniki E
    Thorax; 1990 Sep; 45(9):666-9. PubMed ID: 2145654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of clinical studies carried out in Italy with almitrine bismesylate.
    Grassi V; Tantucci C; Sorbini CA; Grassi C; Cerveri I; Rampulla C; Bottino G; Giacometti A; Blasi A; Pezza A
    Eur J Respir Dis Suppl; 1986; 146():671-6. PubMed ID: 3536560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of almitrine at rest and on exercise in COPD patients.
    Feist H
    Eur J Respir Dis Suppl; 1986; 146():651-5. PubMed ID: 3096765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
    Stradling JR; Nicholl CG; Cover D; Davies EE; Hughes JM; Pride NB
    Eur J Respir Dis Suppl; 1983; 126():255-64. PubMed ID: 6373340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
    Bardsley PA; Howard P; DeBacker W; Vermeire P; Mairesse M; Ledent C; Radermecker M; Bury T; Ansquer J
    Eur Respir J; 1991 Mar; 4(3):308-10. PubMed ID: 1907566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
    Sadoul P
    Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Almitrine as a long term treatment for chronic obstructive pulmonary disease.
    Kauffmann F
    Bull Eur Physiopathol Respir; 1987; 23(6):667. PubMed ID: 2899444
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of chronic obstructive bronchitis with almitrine].
    Pilheu JA
    Medicina (B Aires); 1987; 47(4):442. PubMed ID: 2898724
    [No Abstract]   [Full Text] [Related]  

  • 59. Nocturnal desaturation in patients with bronchitis and emphysema.
    Bonsignore G
    Eur J Respir Dis Suppl; 1983; 126():291-4. PubMed ID: 6586443
    [No Abstract]   [Full Text] [Related]  

  • 60. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease.
    Bardsley PA; Tweney J; Morgan N; Howard P
    Thorax; 1991 Jul; 46(7):493-8. PubMed ID: 1908604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.